139 related articles for article (PubMed ID: 12142637)
21. Integration of olanzapine determinations in a HPLC-diode array detection system for routine psychotropic drug monitoring.
Llorca PM; Coudore F; Corpelet C; Buyens A; Hoareau M; Eschalier A
Clin Chem; 2001 Sep; 47(9):1719-21. PubMed ID: 11514415
[No Abstract] [Full Text] [Related]
22. Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection.
Gervasini G; Vizcaíno S; Herráiz AG; Benítez J; Carrillo JA
Clin Chem; 2003 Dec; 49(12):2088-91. PubMed ID: 14633885
[No Abstract] [Full Text] [Related]
23. A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism.
Lucas RA; Gilfillan DJ; Bergstrom RF
Eur J Clin Pharmacol; 1998 Oct; 54(8):639-43. PubMed ID: 9860152
[TBL] [Abstract][Full Text] [Related]
24. Investigation of target plasma concentration-effect relationships for olanzapine in schizophrenia.
Fellows L; Ahmad F; Castle DJ; Dusci LJ; Bulsara MK; Ilett KF
Ther Drug Monit; 2003 Dec; 25(6):682-9. PubMed ID: 14639054
[TBL] [Abstract][Full Text] [Related]
25. Olanzapine serum concentrations lowered by concomitant treatment with carbamazepine.
Licht RW; Olesen OV; Friis P; Laustsen T
J Clin Psychopharmacol; 2000 Feb; 20(1):110-2. PubMed ID: 10653223
[No Abstract] [Full Text] [Related]
26. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
Martin H; Slyk MP; Deymann S; Cornacchione MJ
J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
[TBL] [Abstract][Full Text] [Related]
27. The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine.
Haslemo T; Refsum H; Molden E
Br J Clin Pharmacol; 2011 Apr; 71(4):611-5. PubMed ID: 21395655
[TBL] [Abstract][Full Text] [Related]
28. Olanzapine concentrations in clinical serum and postmortem blood specimens--when does therapeutic become toxic?
Robertson MD; McMullin MM
J Forensic Sci; 2000 Mar; 45(2):418-21. PubMed ID: 10782964
[TBL] [Abstract][Full Text] [Related]
29. Fully automated on-line determination of olanzapine in serum for routine therapeutic drug monitoring.
Olesen OV; Poulsen B; Linnet K
Ther Drug Monit; 2001 Feb; 23(1):51-5. PubMed ID: 11206044
[TBL] [Abstract][Full Text] [Related]
30. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
Janowsky DS; Barnhill LJ; Davis JM
J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
[TBL] [Abstract][Full Text] [Related]
31. Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia.
An H; Fan H; Yun Y; Chen S; Qi S; Ma B; Shi J; Wang Z; Yang F
Front Psychiatry; 2022; 13():930457. PubMed ID: 35800023
[TBL] [Abstract][Full Text] [Related]
32. Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
Bogusz MJ; Krüger KD; Maier RD; Erkwoh R; Tuchtenhagen F
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):257-69. PubMed ID: 10517347
[TBL] [Abstract][Full Text] [Related]
33. Metabolic and endocrinal effects of N-desmethyl-olanzapine in mice with obesity: Implication for olanzapine-associated metabolic changes.
Zhang X; Zhao Y; Shao H; Zheng X
Psychoneuroendocrinology; 2019 Oct; 108():163-171. PubMed ID: 31302499
[TBL] [Abstract][Full Text] [Related]
34. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
Haslemo T; Eikeseth PH; Tanum L; Molden E; Refsum H
Eur J Clin Pharmacol; 2006 Dec; 62(12):1049-53. PubMed ID: 17089108
[TBL] [Abstract][Full Text] [Related]
35. High-dose olanzapine and prolactin levels.
Karagianis JL; Baksh A
J Clin Psychiatry; 2003 Oct; 64(10):1192-4. PubMed ID: 14658967
[TBL] [Abstract][Full Text] [Related]
36. Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detection.
Aravagiri M; Ames D; Wirshing WC; Marder SR
Ther Drug Monit; 1997 Jun; 19(3):307-13. PubMed ID: 9200772
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Valproic Acid on Olanzapine Serum Concentration: A Study Including 2791 Patients Treated With Olanzapine Tablets or Long-Acting Injections.
Tveito M; Smith RL; Høiseth G; Molden E
J Clin Psychopharmacol; 2019; 39(6):561-566. PubMed ID: 31688390
[TBL] [Abstract][Full Text] [Related]
38. Concomitant use of carbamazepine and olanzapine and the effect on some behavioral functions in rats.
Nowakowska E; Kus K; Polański A; Burda K; Nowakowska A; Sadowski C
Pharmacol Rep; 2011; 63(2):372-80. PubMed ID: 21602592
[TBL] [Abstract][Full Text] [Related]
39. Fatal overdose of olanzepine.
Elian AA
Forensic Sci Int; 1998 Feb; 91(3):231-5. PubMed ID: 9530833
[TBL] [Abstract][Full Text] [Related]
40. Plasma olanzapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1999-2009.
Patel MX; Bowskill S; Couchman L; Lay V; Taylor D; Spencer EP; Flanagan RJ
J Clin Psychopharmacol; 2011 Aug; 31(4):411-7. PubMed ID: 21694620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
